Skip to main content

$25 Million Gates Grant To Jump Start HIV Vaccine Research

Early this month, the International AIDS Vaccine Initiative (IAVI) announced that it had received the largest single grant ever made for AIDS research. The William A. Gates Foundation, which gave IAVI $1.5 million last June, granted IAVI $25 million over a five-year period, which the organization will use in part for work on two to three new HIV-vaccine candidates. IAVI, a New York City-based international scientific organization created to aid in bringing HIV vaccines and technology to develo

Written byMyrna Watanabe
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

Early this month, the International AIDS Vaccine Initiative (IAVI) announced that it had received the largest single grant ever made for AIDS research. The William A. Gates Foundation, which gave IAVI $1.5 million last June, granted IAVI $25 million over a five-year period, which the organization will use in part for work on two to three new HIV-vaccine candidates.

IAVI, a New York City-based international scientific organization created to aid in bringing HIV vaccines and technology to developing nations and making such vaccines affordable, now can fund research on more vaccine candidates. Seth Berkley, IAVI's president, says that the funds can be put toward more studies on the vectors researchers currently have, working on the process engineering for vaccines under development, working on new vectors, and determining what genes should be in a potential vaccine.

Berkley hopes that IAVI can begin human clinical trials in Kenya with an MVA (modifed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

Related Topics

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
Engineering Bispecific Antibodies Against Emerging Viruses

Engineering Bispecific Antibodies Against Emerging Viruses

innovative-research-horizontal-lock-inverted-rgb-900px-w-72ppi
Advancing Research With Humanized Mouse Models

Advancing Research with Next-Generation Humanized Mouse Models

bioxcell
3d illustration showing amyloid plaques in Alzheimer's disease

Best Practices for Blood-Based Amyloid Pathology Testing

fujirebio logo
Optimizing Critical Steps in T-Cell Engineering

Optimizing Critical Steps in T-Cell Engineering

Fujifilm

Products

Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics
Abstract conceptual image of AI technology for medical science research.

Exploring a New Era of Pharmaceutical Innovation

A photograph of plastic fragments floating in water, symbolizing contamination from sample storage tubes.

LVL SAFE® 2D-Coded Tubes: The Perfect Tube for Your Sample

AutoGen